< Key Hightlight >

MARKET OUTLOOK

The ECG equipment market in North America is estimated to develop with 4.85% of CAGR in the projected years 2021-2028. The United States and Canada together comprise the market in this region.

The ECG equipment market in the United States is estimated to progress due to the presence of a well-developed healthcare infrastructure and the rising adoption of advanced cardiovascular solutions. There is also a surge in the obese population, with high susceptibility to various CVD. This, along with the growing unhealthy lifestyle habits, is expected to enhance the market growth. Moreover, the increase in the healthcare expenditure to develop innovative products for disease monitoring will also contribute to the US market’s growth.

ECG devices have been available for a long time. However, there has been a continuous evolution in technology every year, with the need to observe patients for an extended period. Also, Mobile Cardiac Outpatient Telemetry (MCOT) is witnessing a high adoption rate In the United States. Looking at the need for further affordable solutions, GE healthcare launched the portable MAC 800 ECG.

In May 2019, AliveCor received approval from the US FDA for KardiaMobile 6L, the first six-lead personal ECG equipment. Earlier, in October 2017, Abbott received clearance from the FDA for the Confirm Rx Insertable Cardiac Monitor (ICM). Thus, the US is the market leader in North America, and all these developments are aiding the overall market growth.

COMPETITIVE OUTLOOK

Some of the prime players in the smart fleet management market include CompuMed Inc, Siemens Healthineers AG, GE Healthcare, McKesson Corporation, Hill Rom Holdings Inc, Mindray Medical International Limited, Fukuda Denshi Co Ltd, and Schiller AG.